UNSPSC 51171526: Troxipide

This classification denotes a piperidine with the molecular formula C15H22N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W6QJX1Q00Z, chemically known as 3,4,5-trimethoxy-n-(3-piperidyl)benzamide but generally known as troxipide, which bears US NIH Compound Identifier 5597. European Medicines Agency schedules Troxipide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11353MIG. World Health Organization schedules troxipide in its Anatomical Therapeutic Chemical (ATC) Classification.

TROXIPIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule troxipide under HS 29333999 and SITC 51574. As of Q4 2014, TROXIPIDE remains the US FDA Preferred Term for this commodity. SMILES: O=C(NC1CCCNC1)C1CC(OC)C(OC)C(OC)C1.

UNSPSC 51171526 Troxipide (Commodity) encompasses drug-testing products and services procured by state and local correction, health, and human services agencies. Based on recent state solicitations, the code covers specimen collection and analysis services for offender drug testing programs, including immunoassay screening and confirmatory testing (LC/MS/MS or GC/MS), alternative testing methodologies (oral fluid, hair), and lab operations meeting SAMHSA, state, and CAP certification requirements. State health and human services commissions also use the code for broader pharmaceutical procurement initiatives, including generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers. Issuing bodies include state departments of criminal justice community supervision and corrections, state health and human services commissions, and multistate cooperative purchasing alliances serving state and local government facilities.

Recent activity centers in Texas and Minnesota. Collin County Community Supervision and Corrections Department issued RFP 2026-327 (posted July 9, 2026, due July 23, 2026) for offender specimen collection and drug testing services, estimated at $600,000 over two years with three optional one-year renewals, requiring staffing of two collection sites, lab certification, and per-test pricing for screening and confirmatory panels supporting approximately 25,031 annual tests. The Texas Health and Human Services Commission issued a Request for Information (posted March 27, 2026, due April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs for self-insured state employee health plans, a market-research phase preceding formal solicitation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), with awarded vendor lists to be provided to wholesalers by May 15, 2026 and agreements effective July 1, 2026.